Luteolin's Effects on Breast Cancer Cells
Author Information
Author(s): Barry M. Markaverich, Kevin Shoulars, Mary Ann Rodriguez
Primary Institution: Baylor College of Medicine
Hypothesis
Luteolin regulates estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells.
Conclusion
Luteolin inhibits the proliferation of MCF-7 breast cancer cells by regulating specific genes involved in estrogen signaling and the cell cycle.
Supporting Evidence
- Luteolin downregulated 840 genes and upregulated 772 genes in MCF-7 cells.
- Luteolin treatment decreased histone H4 acetylation at the PLK1 promoter.
- Luteolin inhibited the expression of several key genes involved in the estrogen signaling pathway.
Takeaway
Luteolin is a natural compound that helps stop breast cancer cells from growing by changing how certain genes work.
Methodology
MCF-7 cells were treated with estradiol and luteolin, followed by microarray analysis and qPCR to assess gene expression.
Limitations
The study did not assess long-term effects of luteolin on protein expression.
Participant Demographics
MCF-7 human breast cancer cells.
Statistical Information
P-Value
p<0.0001
Confidence Interval
90%
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website